MiR-1246: A new link of the p53 family with cancer and Down syndrome

61Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Since the discovery of miRNAs, a number of miRNAs have been identified as p53's transcriptional targets. Most of them are involved in regulation of the known p53 functions, such as cell cycle, apoptosis and senescence. Our recent study revealed miR-1246 as a novel target of p53 and its analogs p63 and p73 to suppress the expression of DYRK1A and consequently activate NFAT, both of which are associated with Down syndrome and possibly with tumorigenesis. This finding suggests that miR-1246 might serve as a likely link of the p53 family with Down syndrome. Here, we provide some prospective views on the potential role of the p53 family in Down syndrome via miR-1246 and propose a new p53-miR-1246-DYRK1A- NFAT pathway in cancer. © 2012 Landes Bioscience.

Cite

CITATION STYLE

APA

Liao, J. M., Zhou, X., Zhang, Y., & Lu, H. (2012, July 15). MiR-1246: A new link of the p53 family with cancer and Down syndrome. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.20809

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free